BOSTON--(BUSINESS WIRE)--On June 29, 2012, H&Q Life Sciences Investors paid a quarterly stock distribution of $0.29 per share. It is estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on the sale of securities is $42,911,408, of which $14,885,146 represents net unrealized appreciation of portfolio securities.
